CAPACITES

Their core work

CAPACITES is a private technology transfer company based in Nantes, France, operating as a third-party service provider linked to Nantes Université. They deliver specialized contract research and technical expertise in areas ranging from advanced manufacturing to regenerative medicine and industrial biotechnology. Their consistent role as a third party across all H2020 projects indicates they supply targeted scientific services — lab work, testing, or technical know-how — rather than leading research agendas themselves.

What they specialise in

How they've shifted over time

CAPACITES began with manufacturing-oriented work (COROMA, 2016) before shifting toward life sciences and biotechnology infrastructure. From 2017 onward, their projects increasingly focused on industrial biotechnology (IBISBA), regenerative medicine (iPSpine), and building research infrastructure for translational science. The trend shows a clear move from mechanical/industrial applications toward biotech and health, with growing emphasis on public-private partnership models for research infrastructure.

CAPACITES is deepening its role in industrial biotechnology infrastructure and health applications, making them a relevant partner for bio-based manufacturing and translational medicine projects.

How they like to work

CAPACITES operates exclusively as a third-party contributor, meaning they are brought in by consortium partners to deliver specific expertise rather than applying directly to calls. With 62 unique partners across 15 countries, they have a broad network but a deliberately narrow role — providing specialized services on demand. This makes them a low-overhead, focused contributor: easy to integrate into a consortium when you need specific technical capabilities from the Nantes research ecosystem.

Despite their small project count, CAPACITES has worked with 62 different organizations across 15 countries, reflecting the large consortium sizes of the projects they contribute to. Their network spans Western and Southern Europe with strong ties to biotech and manufacturing research communities.

What sets them apart

CAPACITES occupies a distinctive niche as a university-linked private SME that acts as a bridge between academic research in Nantes and EU-funded project consortia. Their value lies in providing access to university-grade scientific infrastructure and expertise through a flexible, commercially oriented entity. For consortium builders, this means you get the depth of a major French university with the contracting agility of a private company.

Highlights from their portfolio

• iPSpine
  Ambitious regenerative medicine project applying induced pluripotent stem cells to spinal disc repair — represents CAPACITES' highest-impact health sector contribution.
• IBISBA 1.0
  Major European research infrastructure project for industrial biotechnology, establishing a distributed network that CAPACITES continued supporting through the PREP-IBISBA preparatory phase.
• COROMA
  Their earliest H2020 project and only manufacturing-sector involvement, focused on cognitive robotics for flexible metal and composite part production.